7-Bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one, 1g

4-Methoxyphenyl 3-O-Allyl-4,6-O-benzylidene-2-O-(4-methylbenzoyl)-beta-D-galactopyranoside>98.0%(HPLC)1g

Methyl 4-(cyanomethyl)benzoate, 95.0%, 5g

Ru(OAc)2[(R)-tolbinap]1g

4-(4-Hydroxybenzyl)tetrahydro-2H-pyran-4-carboxylic acid, 98%, 5g

(3-Bromo-5-fluoropyridin-2-yl)methanamine hydrochloride, 97%, 1g

N-(2-Aminoethyl)-5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanamide, 95.0%, 1g

1-Methyl L-Aspartate>98.0%(T)5g

3-phenylcyclobutanone, 95.0%, 10g

Methyl 2-(chlorosulfonyl)-4-fluorobenzoate, 97%, 250mg

2-Chloro-3-nitroisonicotinic acid, 95.0%, 25g

4-Methyl-3-((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-4H-1,2,4-triazole, 97%, 10mg

2-Mercaptoacetamide (10% in solution NH3/MeOH), 95.0%, 5g